GL1X · GenesisL1 explorer

MolNFT v1 · #13536 · protein

Porcine kidney fructose-1,6-bisphosphatase complexed with an AMP-site inhibitor

1LEV: “Porcine kidney fructose-1,6-bisphosphatase complexed with an AMP-site inhibitor”. X-ray diffraction, 3 ligands (F6P, CLI, MN), 7 pockets (best druggability 0.55). MolNFT v1 #13536 on GenesisL1: 3D structure, binding sites and…

PDB
1LEV
Type
protein
Length
622 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fructose-1,6-bisphosphatase
EC
3.1.3.11
UniProt
P00636
Ligands
F6P, CLI, MN
Pockets
7 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, FFructose-1,6-bisphosphatase (EC 3.1.3.11)protein31138% helix, 27% strandP00636

Ligands and binding sites

  • F6P · 6-O-phosphono-beta-D-fructofuranose · ligand · 2 copies · chains A, F
  • CLI · 3-(2-carboxy-ethyl)-4,6-dichloro-1H-indole-2-carboxylic acid · ligand · 2 copies · chains A, F
  • MN · Manganese (II) ion · metal · 4 copies · chains A, F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11420.550.8221CLI
22020.540.7841F6P, MN
31630.540.7924CLI
41230.480.8025F6P, MN
51250.440.7721empty

Interfaces

1 interface between chains.

  • A–F · 2188 Ų buried · 23 hydrogen bonds · protein-protein

Compared structures

  • 1LEV · Porcine kidney fructose-1,6-bisphosphatase complexed with an AMP-site inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P00636 · AlphaFold monomer V2.0 prediction for fructose-1,6-bisphosphatase 1 (P00636) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.